3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
40
Myelodysplastic Syndromes
8
Leukemia, Biphenotypic, Acute
6
Leukemia
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Myeloproliferative Disorders
3
Leukemia, Myelomonocytic, Chronic
3
Neoplasm, Residual
2
Leukemia, Myelomonocytic, Acute
2
Leukemia, Myeloid
2
Blast Crisis
2
Sarcoma, Myeloid
1
Neoplasms by Histologic Type
1
Myelodysplastic-Myeloproliferative Diseases
1
Lymphoma
1
Liver Neoplasms
1
Leukemia, Promyelocytic, Acute
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Monocytic, Acute
1
Leukemia, Megakaryoblastic, Acute
1
Leukemia, Erythroblastic, Acute
1
Leukemia, Eosinophilic, Acute
1
Leukemia, Basophilic, Acute
1
Hematologic Neoplasms
1
Down Syndrome
1
Congenital Abnormalities
1
Carcinoma, Hepatocellular
1
Anemia, Refractory, with Excess of Blasts
1
Interventions
nilotinib
2
asciminib
2
Dasatinib
2
Cyclophosphamide
2
fludarabine
1
bosutinib
1
Vincristine
1
Prednisone
1
Mitoxantrone
1
Methotrexate
1
Mercaptopurine
1
Imatinib Mesylate
1
Etoposide
1
Dexamethasone
1
Daunorubicin
1
Cytarabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Philadelphia Chromosome
×
Idarubicin
×
1 year
×
Clear all
No trials found.